OA10479A - Apolipoprotein-b synthesis inhibitors - Google Patents
Apolipoprotein-b synthesis inhibitors Download PDFInfo
- Publication number
- OA10479A OA10479A OA60997A OA60997A OA10479A OA 10479 A OA10479 A OA 10479A OA 60997 A OA60997 A OA 60997A OA 60997 A OA60997 A OA 60997A OA 10479 A OA10479 A OA 10479A
- Authority
- OA
- OAPI
- Prior art keywords
- formula
- amino
- alkyl
- methyl
- ch2ch3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203120 | 1994-10-27 | ||
| US08/455,304 US5521186A (en) | 1994-10-27 | 1995-05-31 | Apolipoprotein-β synthesis inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10479A true OA10479A (en) | 2002-04-09 |
Family
ID=26136684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60997A OA10479A (en) | 1994-10-27 | 1997-04-25 | Apolipoprotein-b synthesis inhibitors |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5929075A (bg) |
| EP (1) | EP0788496B1 (bg) |
| JP (1) | JP3025907B2 (bg) |
| KR (1) | KR100227231B1 (bg) |
| CN (1) | CN1068000C (bg) |
| AP (1) | AP779A (bg) |
| AT (1) | ATE198889T1 (bg) |
| AU (1) | AU697744C (bg) |
| BG (1) | BG63694B1 (bg) |
| BR (1) | BR9509436A (bg) |
| CA (1) | CA2203274C (bg) |
| CY (1) | CY2256B1 (bg) |
| CZ (1) | CZ286476B6 (bg) |
| DE (3) | DE122007000005I1 (bg) |
| DK (1) | DK0788496T3 (bg) |
| ES (1) | ES2155535T3 (bg) |
| FI (1) | FI119548B (bg) |
| GR (1) | GR3035519T3 (bg) |
| HR (1) | HRP950532B1 (bg) |
| HU (1) | HU219862B (bg) |
| IL (1) | IL115771A (bg) |
| LU (1) | LU91306I2 (bg) |
| NO (1) | NO311937B1 (bg) |
| NZ (1) | NZ295353A (bg) |
| OA (1) | OA10479A (bg) |
| PT (1) | PT788496E (bg) |
| RO (1) | RO118715B1 (bg) |
| SK (1) | SK281908B6 (bg) |
| TR (1) | TR199501295A2 (bg) |
| WO (1) | WO1996013499A1 (bg) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE216238T1 (de) * | 1997-11-03 | 2002-05-15 | Janssen Pharmaceutica Nv | Arzneimittel enthaltend lipidsenkende verbindungen |
| CN1308523A (zh) * | 1998-04-27 | 2001-08-15 | 詹森药业有限公司 | 含有用降脂剂和聚合物包衣的丸芯的微丸 |
| EP1140917B1 (en) | 1998-12-22 | 2003-03-26 | Janssen Pharmaceutica N.V. | S-oxide lipid lowering compounds |
| DE19945982A1 (de) | 1999-09-24 | 2001-03-29 | Knoll Ag | Geschwindigkeitsbestimmte Partikel |
| US20050132022A1 (en) * | 2003-12-12 | 2005-06-16 | International Business Machines Corporation | Computer system with LAN-based I/O |
| US20080234291A1 (en) * | 2004-01-21 | 2008-09-25 | Marc Karel Jozef Francois | Mitratapide Oral Solution |
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
| US20080280922A1 (en) * | 2004-04-09 | 2008-11-13 | Marc Alois Celine Maria Engelen | Intermittent Dosing Regimen For Overweight and Obese Subjects |
| US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| JP2008542255A (ja) * | 2005-05-27 | 2008-11-27 | ファイザー・プロダクツ・インク | 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用 |
| JP2009503050A (ja) * | 2005-08-04 | 2009-01-29 | ファイザー・リミテッド | ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物 |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| US8138188B2 (en) * | 2006-02-23 | 2012-03-20 | Pfizer Inc. | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| CA2669311C (en) | 2006-11-13 | 2011-09-20 | Pfizer Products Inc. | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
| JP5350367B2 (ja) | 2007-05-25 | 2013-11-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | （２ｓ−シス）−２−（ブロモメチル）−２−（４−クロロフェニル）−１，３−ジオキソラン−４−メタノールメタンスルホネート（エステル）の改良された合成 |
| KR101280786B1 (ko) * | 2008-08-06 | 2013-07-05 | 화이자 리미티드 | 멜라노코르틴 4 작용제로서 다이아제핀 및 다이아조칸 화합물 |
| CA2798002C (en) * | 2010-05-19 | 2019-12-03 | Sandoz Ag | Process for the preparation of chiral triazolones |
| MX2020009228A (es) | 2018-03-08 | 2021-01-08 | Incyte Corp | Compuestos diolicos de aminopirazina como inhibidores de fosfoinositida 3-cinasas-gamma. |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4313953A (en) * | 1978-06-23 | 1982-02-02 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4267179A (en) * | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4766125A (en) * | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
| US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| NZ223799A (en) * | 1987-03-25 | 1989-12-21 | Janssen Pharmaceutica Nv | Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| AU6359594A (en) * | 1993-03-04 | 1994-09-26 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| US5521186A (en) * | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
-
1995
- 1995-10-19 EP EP95937804A patent/EP0788496B1/en not_active Expired - Lifetime
- 1995-10-19 US US08/817,247 patent/US5929075A/en not_active Expired - Lifetime
- 1995-10-19 NZ NZ295353A patent/NZ295353A/en not_active IP Right Cessation
- 1995-10-19 PT PT95937804T patent/PT788496E/pt unknown
- 1995-10-19 KR KR1019970702662A patent/KR100227231B1/ko not_active IP Right Cessation
- 1995-10-19 RO RO97-00812A patent/RO118715B1/ro unknown
- 1995-10-19 JP JP8514288A patent/JP3025907B2/ja not_active Expired - Fee Related
- 1995-10-19 CA CA002203274A patent/CA2203274C/en not_active Expired - Fee Related
- 1995-10-19 DK DK95937804T patent/DK0788496T3/da active
- 1995-10-19 ES ES95937804T patent/ES2155535T3/es not_active Expired - Lifetime
- 1995-10-19 DE DE1995619995 patent/DE122007000005I1/de active Pending
- 1995-10-19 HU HU9701956A patent/HU219862B/hu not_active IP Right Cessation
- 1995-10-19 SK SK507-97A patent/SK281908B6/sk not_active IP Right Cessation
- 1995-10-19 CZ CZ19971198A patent/CZ286476B6/cs not_active IP Right Cessation
- 1995-10-19 CN CN95195885A patent/CN1068000C/zh not_active Expired - Fee Related
- 1995-10-19 DE DE69519995T patent/DE69519995T2/de not_active Expired - Lifetime
- 1995-10-19 AU AU38680/95A patent/AU697744C/en not_active Ceased
- 1995-10-19 AP APAP/P/1997/000968A patent/AP779A/en active
- 1995-10-19 DE DE122007000005C patent/DE122007000005I2/de active Active
- 1995-10-19 BR BR9509436A patent/BR9509436A/pt not_active IP Right Cessation
- 1995-10-19 WO PCT/EP1995/004111 patent/WO1996013499A1/en active IP Right Grant
- 1995-10-19 AT AT95937804T patent/ATE198889T1/de active
- 1995-10-20 TR TR95/01295A patent/TR199501295A2/xx unknown
- 1995-10-26 IL IL11577195A patent/IL115771A/xx not_active IP Right Cessation
- 1995-10-27 HR HR950532A patent/HRP950532B1/xx not_active IP Right Cessation
-
1997
- 1997-04-10 BG BG101402A patent/BG63694B1/bg unknown
- 1997-04-24 NO NO19971895A patent/NO311937B1/no not_active IP Right Cessation
- 1997-04-25 FI FI971784A patent/FI119548B/fi not_active IP Right Cessation
- 1997-04-25 OA OA60997A patent/OA10479A/en unknown
-
2001
- 2001-03-05 GR GR20010400359T patent/GR3035519T3/el unknown
-
2002
- 2002-01-04 CY CY0200004A patent/CY2256B1/xx unknown
-
2007
- 2007-01-17 LU LU91306C patent/LU91306I2/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA10479A (en) | Apolipoprotein-b synthesis inhibitors | |
| US5521186A (en) | Apolipoprotein-β synthesis inhibitors | |
| CA2382355C (en) | Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent | |
| CZ284318B6 (cs) | Triazolové deriváty, způsob jejich přípravy a použití a meziprodukty tohoto postupu | |
| JPWO2007111212A1 (ja) | トリアゾロン誘導体 | |
| JPH10506652A (ja) | トリアゾール系抗真菌薬 | |
| JP3415865B2 (ja) | 光学活性アゾール化合物およびその用途 | |
| EP0871626B1 (en) | triazolones as apolipoprotein-b synthesis inhibitors | |
| MXPA97003074A (en) | Synthesis of apoliprotein synthesis |